Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Slides:

Advertisements

Similar presentations

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Stephen R. Broderick, MD, MPHS

Two decades of pediatric lung transplant in the United States: Have we improved? Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.

The use of extended criteria donors decreases one-year survival in high-risk lung recipients: A review of the United Network of Organ Sharing Database

Lobar lung transplantation: One size fits all

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery? Niv Ad, MD, Sari D. Holmes, PhD, Deborah J.

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Ground glass opacity of the lung: The veil that needs lifting

Survival after resection of synchronous non–small cell lung cancer

Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Mark E. Ginsburg, MD, Byron M. Thomashow, MD, William A

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

Marye J. Gleva, MD, Charles B. Huddleston, MD

Go on-pump or off-pump in diabetic patients?

Perioperative atrial tachycardia is associated with increased mortality in infants undergoing cardiac surgery Pirouz Shamszad, MD, Antonio G. Cabrera,

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

The lord of the rings Antonio Miceli, MD, PhD

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Predictors of survival in lung torsion: A systematic review and pooled analysis Jie Dai, PhD, Dong Xie, MD, Haifeng Wang, MD, Wenxin He, MD, Yiming Zhou,

David P. Mason, MD, Lillian H. Batizy, MS, Jeffrey Wu, MD, Edward R

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery Su-Kiat Chua, MD,

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Bartley P. Griffith, MD, FACS, FRCS

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

The influence of retransplantation on survival for pediatric lung transplant recipients Ryuichi Waseda, MD, PhD, Alberto Benazzo, MD, Konrad Hoetzenecker,

Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction

Stephen R. Broderick, MD, MPHS

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.

Third-time lung transplantation in a patient with cystic fibrosis

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity? Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek.

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Surgical outcomes after cardiac surgery in liver transplant recipients

The continuing challenge of congenital heart disease in China

“The more things change…”: The challenges ahead

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Why arch curvature affects arch resistance

Apples remain apples NO matter what

Did you like Terminator 3 better than Terminator 2

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Risk factors for primary graft dysfunction after lung transplantation

Presentation transcript:

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester M. Black, MD, PhD, Karen S. McCoy, MD, Stephen Kirkby, MD, Joseph D. Tobias, MD, Heidi M. Mansour, PhD, Bryan A. Whitson, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 150, Issue 3, Pages 707-713.e2 (September 2015) DOI: 10.1016/j.jtcvs.2015.06.041 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Patient inclusion and exclusion criteria for patients with cystic fibrosis listed for lung transplantation but who did not undergo transplant and subsequent univariate analysis, Kaplan-Meier survival curve, multivariate Cox analysis, and propensity-score matching. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 707-713.e2DOI: (10.1016/j.jtcvs.2015.06.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan-Meier survival functions comparing diabetes and no diabetes in patients with cystic fibrosis listed for lung transplantation (n = 672). Log-rank test: χ2 square1: 6.9; P = .0085. CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 707-713.e2DOI: (10.1016/j.jtcvs.2015.06.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Patient inclusion and exclusion criteria for cases with cystic fibrosis after lung transplantation and subsequent univariate analysis, Kaplan-Meier survival curve, multivariate Cox analysis, and propensity-score matching. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 707-713.e2DOI: (10.1016/j.jtcvs.2015.06.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Kaplan-Meier survival functions comparing diabetes and no diabetes in patients with cystic fibrosis after lung transplantation (n = 1464). Log-rank test: χ2 square1: 0.0; P = .95. CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 707-713.e2DOI: (10.1016/j.jtcvs.2015.06.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Diabetes did not influence survival in patients with cystic fibrosis after lung transplantation. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 707-713.e2DOI: (10.1016/j.jtcvs.2015.06.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions